A BILL 
To amend the Public Health Service Act to authorize grants 
to certain States to inform patients about the risks of 
opioids and their analogues, and for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Opioid Patients’ Right 
4
to Know Act of 2021’’. 
5
19:43 Mar 13, 2021
H1185
2 
•HR 1185 IH
SEC. 2. GRANT PROGRAM TO INFORM PATIENTS ABOUT 
1
THE RISKS OF OPIOIDS AND THEIR ANA-
2
LOGUES. 
3
Part J of title III of the Public Health Service Act 
4
(42 U.S.C. 280b et seq.) is amended by inserting after 
5
section 392A (42 U.S.C. 280b–1) the following: 
6
‘‘SEC. 392B. GRANT PROGRAM TO INFORM PATIENTS ABOUT 
7
THE RISKS OF OPIOIDS AND THEIR ANA-
8
LOGUES. 
9
‘‘(a) IN GENERAL.—The Secretary, acting through 
10
the Director of the Centers for Disease Control and Pre-
11
vention, shall award one grant (over the life of the pro-
12
gram under this section) to each eligible State to inform 
13
covered health care providers about— 
14
‘‘(1) the requirement of the State described in 
15
subsection (b); and 
16
‘‘(2) recommendations for safe opioid pre-
17
scribing. 
18
‘‘(b) ELIGIBILITY.—To be eligible to receive a grant 
19
under subsection (a), a State must have in effect a law 
20
or regulation requiring covered health care providers, be-
21
fore issuing a new prescription for a covered drug or ana-
22
logue, to inform the patient involved, and the patient’s 
23
guardian if the patient has a guardian, about— 
24
‘‘(1) the risks of such covered drug or analogue; 
25
19:43 Mar 13, 2021
H1185
3 
•HR 1185 IH
‘‘(2) the addictive qualities of such covered drug 
1
or analogue; and 
2
‘‘(3) non-opioid treatments to such covered 
3
drug or analogue, as appropriate. 
4
‘‘(c) GRANT AMOUNT.—The amount of a grant to a 
5
State under this section— 
6
‘‘(1) shall be greater than the amount of each 
7
grant to a State with a smaller number of covered 
8
health providers, as estimated by the Secretary; 
9
‘‘(2) shall not exceed $1,000,000; and 
10
‘‘(3) subject to the availability of funds, shall 
11
not be less than $750,000. 
12
‘‘(d) DEFINITIONS.—For purposes of this section: 
13
‘‘(1) COVERED
DRUG
OR
ANALOGUE.—The 
14
term ‘covered drug or analogue’ means a drug that 
15
is or contains an opioid (as defined in section 102 
16
of the Controlled Substances Act) or an analogue of 
17
an opioid. 
18
‘‘(2) COVERED HEALTH CARE PROVIDER.—The 
19
term ‘covered health care provider’ means a health 
20
care provider who issues prescriptions for a covered 
21
drug or analogue for the relief of acute pain. 
22
19:43 Mar 13, 2021
H1185
4 
•HR 1185 IH
‘‘(e) AUTHORIZATION OF APPROPRIATIONS.—There 
1
is authorized to be appropriated to carry out this section 
2
$10,000,000 for each of fiscal years 2022 through 2031.’’. 
3
Æ 
19:43 Mar 13, 2021
H1185
